Skip to Content
Contact Form Map & Directions Videos

Search Results: avandia

Avandia Linked to Cardiovascular Issues, Heart Attacks

03/24/2022
Defective Drugs
BY

Rosiglitazone (marketed under the trade name Avandia) is an antidiabetic drug that is used for the treatment of patients with type 2 diabetes. It is one of several antidiabetic drugs sold in the United States—along with Avandamet, Avandaryl, and metformin with sulfonylurea. While the U.S. Food and Drug Administration (FDA) […]

Read More

Avandia and Actos Linked to Macular Edema Vision Problems

06/13/2012
Actos
BY

According to a study published June 11, the users of Actos (pioglitazone) or Avandia (rosiglitazone) may face an increased risk of developing macular edema.  Published in the Archives of Internal Medicine, British researchers collected data on more than 100,000 patients with type 2 diabetes who were enrolled in the British […]

Read More

Actos, Avandia and Bladder Cancer

01/31/2012
Actos
BY

One of the first cases involving a plaintiff who developed bladder cancer as a result of taking the diabetes drug, Actos was filed by Mass Tort Attorneys of Searcy Denney in the Southern District of Florida, Miami Division. This case involves a married executive who lives in the Miami area […]

Read More

Avandia Lawsuits Proceed

01/31/2012
Defective Drugs
BY

The Mass Torts Unit of Searcy Denney filed an individual lawsuit on December 10, 2010 against the manufacturer of Avandia on behalf of a Jacksonville man, who suffered severe congestive heart failure and worsening of his heart disease after ingesting the insulin sensitizer. The case was filed in federal court […]

Read More

Januvia, Byetta, Claims Headed for Appeals Court

10/18/2016
Articles
BY

The fate of diabetic patients who suffered pancreatic or thyroid cancer after ingesting incretin-based therapy drugs is now in the hands of the Ninth Circuit Court of Appeals after the claims were dismissed by the California federal court judge who oversaw the national coordinated litigation. In September of 2016, the […]

Read More

Settlement Over Deceptive Implant Marketing

07/10/2014
Articles
BY

Johnson & Johnson (“J&J”) has reached a four million dollar settlement with the state of Oregon to resolve allegations that J&J improperly marketed its DePuy ASR metal-on-metal hip implants.  J&J has recalled 93,000 ASR hip implants, which had a 12% failure rate in five years. David Hart, Oregon’s Assistant Attorney General […]

Read More

Hear What Our Clients Have To Say

"Every question that I had was answered in mere minutes and the follow through that the staff, secretaries and attorneys had was superior. I have dealt with many, many firms that have all disappointed me and Searcy Denney was by far the most thorough - I highly recommend them!"
Posted By: Susan Baker